Slrx warrants
WebbSalarius Pharmaceuticals Inc. SLRX (U.S.: Nasdaq) View All companies AT CLOSE 3:46 PM EDT 04/10/23 $1.55 USD 0.10 6.90% AFTER HOURS 4:27 PM EDT 04/10/23 $1.52 -0.03 -1.94% AFTER HOURS Vol 313... Webb6 apr. 2024 · Get Salarius Pharmaceuticals Inc (SLRX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Slrx warrants
Did you know?
Webb13 apr. 2024 · About SLRX. Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. Webb24 mars 2024 · SLRX ($2.11) is significantly undervalued by 78.01% relative to our estimate of its Fair Value price of $9.59 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety Significantly Below Fair Value Valuation SLRX is unprofitable, so we... subscribe to Premium to read more.
Webb18 aug. 2024 · En warrant är ett hävstångsinstrument där du som innehavare har rätten att antingen köpa eller sälja underliggande tillgång till ett på förhand bestämt pris och en på … WebbSalarius Pharmaceuticals Inc (SLRX) NASDAQ Aggiungere uno strumento a: 1,9100 -0,1100 ( -5,45 %) 31/03 - Chiuso. Valuta in USD ( Responsabilità) Volume: 44.281 Min-Max gg: 1,8900 - 2,0000 52...
WebbDid you get a call or text from 828-318-9114? View owner's full name, address, public records, and background check for 8283189114 with Whitepages reverse phone lookup. WebbWarrantskolan. I warrantskolan får du veta mer om vad som är bra att tänka på innan du börjar investera i warranter. En warrant är ett värdepapper som ger dig möjligheten att ta del av en akties eller annat värdepappers värdeförändring utan att du behöver köpa eller sälja själva aktien eller värdepappret. Du kan få en hög ...
WebbThe new Common Stock Purchase Warrants will be initially exercisable on the six month anniversary of the date of issuance, have a term of exercise of five (5) year thereafter, …
WebbFind real-time SLRX - Salarius Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. syntax error at or near monthWebbAbout SLRX Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. … syntax error at or near postgresWebbThe Southern Regional Livestock Exchange (SRLX) is located in Moss Vale and is one of the top ten cattle saleyards in the state of New South Wales. The SRLX is currently turning over around 60,000 head of cattle per year, with an annual gross turnover of between $30-35 million dollars. syntax error at or near exceptionWebbLadenburg Thalmann & Co. Inc. is acting as the exclusive placement agent for the transaction. Salarius reduced the exercise price of Exercising Holders’ warrants from … syntax error at or near 13WebbThe latest price target for Salarius Pharmaceuticals ( NASDAQ: SLRX) was reported by HC Wainwright & Co. on Friday, March 11, 2024. The analyst firm set a price target for 4.00 expecting SLRX to ... syntax error at or near timeWebb6 apr. 2024 · Salarius Pharmaceuticals Inc. (NASDAQ: SLRX) stock closed at 1.45 per share at the end of the most recent trading day (a 0.26 % change compared to the prior day closing price) with a volume of 31.69K shares and market capitalization of 3.58M.Is a component of indices and it is traded on NASDAQ exchange. The company belongs in … syntax error at or near identityWebb11 aug. 2024 · Salarius is the recipient of a three-year $16.1 million Cancer Prevention and Research Institute of Texas (CPRIT) New Company Product Development award. … syntax error at or near generated postgresql